Microbial Markers in Colorectal Cancer Detection and Prognosis
- 13 August 2026
- book chapter
- Published by IGI Global Scientific Publishing
- p. 129-160
Abstract
Colorectal cancer (CRC) represents a global health challenge, with increasing incidence rates necessitating effective early detection and prognostic techniques. Recent research has identified microbial markers vital for CRC diagnostics, including Fusobacterium nucleatum and Escherichia coli. The gut microbiome plays a crucial role in tumor development and treatment approaches, with 15-20% of CRC cases showing significant changes in microbial ecosystems that serve as non-invasive biomarkers for early diagnosis and targeted therapies. Microbes like Bacteroides fragilis and Akkermansia muciniphila are linked to various CRC stages, highlighting their influence in disease progression. High levels of Fusobacterium nucleatum notably increase CRC risk, improving diagnostic precision. These microbial indicators may enhance early detection rates by 30% compared to standard methods, while advantageous taxa potentially boost survival rates by 50%. Ongoing research focuses on examining microbial communities in fecal samples to identify CRC signatures and enhance understanding of the disease.Keywords
This publication has 76 references indexed in Scilit:
- Molecular Microbiology Standardization2025
- Evolving landscape of colorectal cancer: Global and regional burden, risk factor dynamics, and future scenarios (the Global Burden of Disease 1990–2050)Ageing Research Reviews, 2025
- Gut microbiota derived short‐chain fatty acids in physiology and pathology: An updateCell Biochemistry and Function, 2024
- Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancerApoptosis, 2024
- Biomarker Profile of Colorectal Cancer: Current Findings and Future PerspectiveJournal of Gastrointestinal Cancer, 2024
- Progress of gut microbiome and its metabolomics in early screening of colorectal cancerClinical and Translational Oncology, 2023
- Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controlsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiomeFolia Microbiologica, 2022
- The Moral Consideration of Artificial Entities: A Literature ReviewScience and Engineering Ethics, 2021
- Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancerMolecular Oncology, 2019